post operative Nausea and vomiting. Nausea with vomiting, unspecified
Conditions
Interventions
Intervention 1: Intervention group 1: gabapentin (razak company) 300mg po, 1hour before surgery. Intervention 2: Intervention group 2: midazolam (caspian) 0.025 mg/kg befor induction. Intervention 3:
Sponsors
Tehran University of Medical Sciences
Eligibility
Sex/Gender
Female
Age
20 Years to 65 Years
Inclusion criteria
Inclusion criteria: The study population of patients referring to Imam Khomeini Hospital and the sample would include patients who are required to perform Mastectomy is referred to Vali Asr operation room. After providing the necessary explanations, patients will be informed of the consent of the study.In this study, patients aged 20 to 65 years who were admitted for mastectomy elective with ASA class 1 and 2, were selected and divided into three groups.
Exclusion criteria
Exclusion criteria: Exit from the study included pre-operative history of use of analgesics and drugs, history of corticosteroid use, history of chronic pulmonary disease, history of postoperative nausea and vomiting, diabetes, motion sickness, history of drug use and antiemetic drugs. And patients with a BMI of 30 kg / m 2
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| The number of vomiting after surgery. Timepoint: Up to 24 hours after surgery. Method of measurement: checklist. | — |
Secondary
| Measure | Time frame |
|---|---|
| Pain severity. Timepoint: since one day after surgery. Method of measurement: question.;Serum intake. Timepoint: while surgery. Method of measurement: quentitive. | — |
Countries
Iran (Islamic Republic of)
Contacts
Public Contactmohammad mojtaba rohani
Tehran University of Medical Sciences
Outcome results
None listed